Evaluation of serum β-carboxy-terminal cross-linking telopeptide of type I collagen as marker of bone resorption in chronic hemodialysis patients

Nephron - Clinical Practice

Volumn 98, Issue 4, 2004, Pages

  Reichel, Helmut ^a   Roth, Heinz Jürgen ^b   Schmidt Gayk, Heinrich ^b  

^a Nephrological Center   (Germany)

^b Limbach Laboratory   (Germany)

Author keywords

crosslaps; CTX; Bone specific alkaline phosphatase; Crosslaps; Hemodialysis; Hyperparathyroidism; Parathyroid hormone; Pyridinolines; Renal bone disease; Tartrate resistant acid phosphatase 5b

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE BONE ISOENZYME; COLLAGEN TYPE 1; OSTEOCALCIN; PARATHYROID HORMONE; TELOPEPTIDE;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BLOOD SAMPLING; BONE; BONE DISEASE; BONE METABOLISM; CALCIUM METABOLISM; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS LINKING; DIURESIS; FEMALE; HEMODIALYSIS PATIENT; HISTOLOGY; HORMONE DETERMINATION; HUMAN; INTERMETHOD COMPARISON; KIDNEY DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN CONTENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; TIME;

ADULT; AGED; BIOLOGICAL MARKERS; BONE RESORPTION; COLLAGEN; COLLAGEN TYPE I; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PEPTIDES; RENAL DIALYSIS;

EID: 11244278652     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081552     Document Type: Article

References (26)

1. Coen G, Mazzaferro S, Ballanti P, Bonucci E, Bondatti F, Manni M, Pasquali M, Perruzza I, Sardella D, Spurio A: Procollagen type I C-terminal extension peptide in predialysis chronic renal failure. Am J Nephrol 1992;12:246-251.
2. Jensen PB, Rasmussen HB, Pedersen FB: Serum concentration of the aminopropeptide of type I procollagen in patients on haemo- and peritoneal dialysis. APMIS 1997;105:371-377.
3. Urena P, Ferreira A, Kung VT, Morieux C, Simon P, Ang KS, Souberbielle JC, Segre GV, Drueke TB, De Vernejoul MC: Serum pyridinoline as a specific marker of collagen breakdown and bone metabolism in hemodialysis patients. J Bone Miner Res 1995;10:932-939.
4. Rosen HN, Moses AC, Garber J, Iloputaife ID, Ross DS, Lee SL, Greenspan SL: Serum CTX: A new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient variability and large changes with bisphosphate therapy. Calcif Tissue Int 2000;66:100-103.
5. Szulc P, Garnero P, Munoz F, Marchand F, Delmas PD: Cross-sectional evaluation of bone metabolism in men. J Bone Miner Res 2001;16:1642-1650.
6. Garnero R, Borel O, Delmas PD: Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis. Clin Chem 2001;47:694-702.
7. Robins SP, Black D, Peterson CR, Reid DM, Duncan A, Seibel MJ: Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone diseases. Eur J Clin Invest 1991;21:310-315.
8. Becker S, Schmidt-Gayk H, Traber L: Free and peptide-bound pyridinium-crosslinks in urine measured in healthy subjects, women after the menopause, and patients with bone metastases; in Schmidt-Gayk H, Blind E, Roth HJ (eds): Calcium-Regulating Hormones and Bone Metabolism: Measurement and Interpretation, ed 2. Heidelberg, Clin Lab Publications, 1997, pp 141-146.
9. Reichel H, Esser A, Roth HJ, Schmidt-Gayk H: Influence of PTH assay methodology on differential diagnosis of renal bone disease. Nephrol Dial Transplant 2003;18:759-768.
10. Bothe V, Schmidt-Gayk H, Armbruster PP, Mayer E: Assay for the diagnosis of hyper- and hypovitaminosis D. Ärztl Lab 1984;30:151-156.
11. Husdan H, Rapaport A, Locke S: Influence of posture on the serum concentration of calcium. Metabolism 1973;22:787-797.
12. Okabe R, Nakatsuka K, Inaba M, Miki T, Naka H, Masaki H, Moriguchi A, Nishizawa Y: Clinical evaluation of the Elecsys Beta-Cross-Laps serum assay, a new assay for degradation products of type I collagen C-telopeptides. Clin Chem 2001;47:1410-1414.
13. Herrmann M, Pape G, Herrmann W: Stability of serum Beta-CrossLaps during storage: Influence of pH and storage temperature. Clin Chem 2001;47:939-940.
14. Schmidt-Gayk H, Spanuth E, Kötting J, Bartl R, Felsenberg D, Pfeilschifter J, Raue F, Roth HJ: Performance evaluation of automated assays for β-CrossLaps, N-MID-osteocalcin and intact parathyroid hormone (BIOROSE Multicenter Study). Clin Chem Lab Med 2004;42:90-95.
15. Pagani F, Bonetti G, Stefini F, Panteghini M: Evaluation of a fully automated assay to measure C-telopeptide of type I collagen in serum. Clin Chem Lab Med 2000;38:1111-1113.
16. Wichers M, Schmidt E, Bidlingmaier F, Klingmüller D: Diurnal rhythm of CrossLaps in human serum. Clin Chem 1999;45:1858-1860.
17. Qvist P, Christgau S, Pedersen BJ, Schlemmer A, Christiansen C: Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTX): Effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting. Bone 2002;31:57-61.
18. Christgau S, Bitsch-Jensen O, Hanover Bjarnason N, Gamwell H, Quvist P, Alexandersen P, Bang Hendriksen D: Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy. Bone 2000;26:505-511.
19. Graf S, Bohner J, Hertel A, Fassbinder W, Wahl HG. Evaluation of β-CrossLaps in haemodialysis patients (abstract). Nephrol Dial Transplant 2003:18(suppl 4):407.
20. Negri AL, Quiroga MA, Bravo M, Marino A, Fradinger E, Bogado CE, Zanchetta JR: Serum CrossLaps as bone resorption marker in peritoneal dialysis. Perit Dial Int 2002;22:628-630.
21. Malyszko J, Wolczynski S, Zbroch E, Brzosko S, Malyszko J, Mysliwiec M: Serum CrossLaps correlations with serum ICTP and urine DPD in hemodialyzed and peritoneally dialyzed patients. Nephron 2001;87:283-285.
22. Malyszko J, Wolcznski S, Malyszko JS, Konstantynowicz J, Kaczmarski M, Mysliwiec M: Correlations of new markers of bone formation and resorption in kidney transplant recipients. Transplant Proc 2003;35:1351-1354.
23. Magnusson P, Sharp CA, Magnusson M, Risteli J, Davie MW, Larsson L: Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms. Kidney Int 2001;60:257-265.
24. Chu P, Chao TY, Lin YF, Janklia AJ, Yam LT: Correlation between histomorphometric parameters of bone resorption and serum type 5b tartrate-resistant acid phosphatase in uremic patients on maintenance hemodialysis. Am J Kidney Dis 2003;41:1052-1059.
25. Seibel MJ, Lang M, Geilenkeuser WJ: Interlaboratory variation of biochemical markers of bone turnover. Clin Chem 2001;47:1443-1450.
26. Milford Ward A: UK NEQAS for bone metabolism 2001. Contact: Dept Immunology, PO Box 994, Sheffield S5 7YT, UK.